Authors


Elizabeth Kiracofe, MD, FAAD

Latest:

Case 2: Male, 35 Years Old

Dr. Elizabeth Kiracofe discusses a case of unstable vitiligo in a 35-year-old male, addressing the impact of an outdoor lifestyle on treatment, the efficacy of topical ruxolitinib, and its utility in difficult-to-repigment areas.



Nathalie Zeitouni, MD, FAAD

Latest:

Considerations for Hedgehog vs Immunotherapy in Patients with Basal Cell Carcinoma

Experts in dermatology comment on the patient considerations required when deciding on systemic treatment for basal cell carcinoma.



Latanya Benjamin, MD, FAAD, FAAP

Latest:

Women's Dermatologic Society: New President Shares Hopes for Enduring Positive Change on Organization and Dermatology

Dermatology Times recently spoke with Latanya Benjamin, MD, FAAD, FAAP, the newly-appointed president of the WDS, to discuss her hopes and goals for her presidency.


Emma Andrus, Associate Editor

Latest:

QUIZ RECAP: Test Your Knowledge of Rosacea Complications and Comorbidities

Earlier this week, we shared our second Rosacea Awareness Month quiz. Review the answers and your responses below.


Killian Meara

Latest:

Skin Cancer Screening Does Little To Improve Melanoma Outcome Disparities

In ethnic and racial minority populations, more than 12,000 standard skin cancer screenings would be done to identify 1 case of melanoma, according to a recent study.


Jared Kaltwasser

Latest:

Post-Acne Vulgaris Scarring Leads to Negative Body Image and Self-Esteem

In a recent study, authors argue that psychosocial impacts should be at the forefront of the discussion in acne scarring, noting that psychopharmacological management may be necessary in instances of severe psychiatric comorbidities.


Klint Peebles, MD

Latest:

Considerations to Best Serve Transgender Patients Seeking Aesthetic Care

Ronda Farah, MD, and her colleagues reviewed how dermatology providers play an important role in transgender aesthetic care.


Neal Bhatia, MD

Latest:

AAD is More Than Just a Conference

Neal Bhatia, MD, shares his insights on successfully navigating AAD and his session highlights on office politics.


Jared Gollob, MD

Latest:

KT-474 Demonstrates Efficacy and Promise in Atopic Dermatitis and Hidradenitis Suppurativa Study

Jared Gollob, MD, Chief Medical Officer of Kymera Therapeutics, spoke with Dermatology Times to discuss these trial results.


Joseph F. Merola, MD, MMSc

Latest:

Psoriasis Case Impressions

Mark G. Lebwohl, MD, and Joseph F. Merola, MD, MMSc, provide impressions to the case and take-home messages for dermatologists and rheumatologists treating psoriasis.


Elizabeth Arthur, MD

Latest:

Psychological Effects of Cosmetic Procedures Extend Far Beneath the Surface

Understanding the underlying motivation for seeking out minimally invasive cosmetic procedures is important to provide individualized and holistic care to patients.


Connor Iapoce

Latest:

Malignancy Risk Low in Secukinumab Treatment

A study finds low risk of malignancy from secukinumab treatment for psoriasis, psoriatic arthritis and ankylosing spondylitis patients, despite limited data.


Jonathan I Silverberg, MD, PhD, MPH

Latest:

Jonathan Silverberg, MD, Previews Upcoming Virtual RAD Conference and Exciting Topics

This year’s virtual atopic dermatitis conference takes place on Sunday, December 10, 2023.


Saranya Wyles, MD, PhD

Latest:

Strategies for Integrating Advanced Skincare Technologies: Ensuring Evidence-Based Practice

Saranya Wyles, MD, PhD, offers guidance on integrating advanced skincare technologies into their practices and the importance of staying updated through events like the Science of Skincare summit.


Nina Ventura, Correspondent

Latest:

Harnessing the Potential of Placental Allografts

Placental tissues provide a promising alternative for addressing cutaneous reconstruction while maintaining the most cosmetically pleasing outcome.


Alan Menter, MD

Latest:

Continuing Medical Education: Three Things to Know About Pustular Psoriasis

Pustular psoriasis (PP) is a rare and potentially serious inflammatory skin disorder affecting about 1% of patients with psoriasis.


Lisa Cristofaro, PharmD, BS, BCACP

Latest:

The Adalimumab Biosimiliar Pipeline: What's Ahead

FDA approvals of these biosimilars started in 2016, but only 1 such product has successfully launched.


Miranda Hester

Latest:

Amy Paller, MD, Discusses Long-Term Safety and Efficacy of Ixekizumab in Kids

Paller discusses the findings of the clinical trial examining the long-term effects of ixekizumab for treating psoriasis in children.




Muneeb Shah, DO

Latest:

Muneeb Shah, DO: Behind the Scenes of Launching a Skin Care Brand

Shah discusses the science behind his products, as well as the challenges he didn’t anticipate when launching Remedy.


Sophia Fruechte

Latest:

Considerations to Best Serve Transgender Patients Seeking Aesthetic Care

Ronda Farah, MD, and her colleagues reviewed how dermatology providers play an important role in transgender aesthetic care.


Junqian Zhang, MD

Latest:

The Importance of Collaboration Between Mohs Surgeons and Urologists

Caleb Kovell, MD and Junqian Zhang, MD demonstrated how teaming up increases the likelihood for positive patient outcomes in Mohs cases on the genitalia and perianal region.



Julie Harper, MD

Latest:

Julie Harper, MD, to Present a Rosacea Research Roundup and Pearls

She shares her top 5 considerations for all dermatology drug prescribers.


Jeanine Downie, MD, FAAD

Latest:

Dermatology Times in France: What La Roche-Posay Products Dermatologists Recommend for Eczema, Acne

Dermatologists Jeanine Downie, DiAnne Davis, and Hope Mitchell reveal the La Roche-Posay products they recommend to patients with dry skin, eczema, and more, at the flagship store in France.


Amy B. Lewis, MD

Latest:

Habits, Cultural Norms, and Rapid Advances In Technology Have Dramatically Changed the Aesthetic Medicine Landscape

Amy B. Lewis, MD, explores the evolution of aesthetic dermatology, delving into injection sophistication, devices, and top procedures.


© 2024 MJH Life Sciences

All rights reserved.